These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 8431010)

  • 1. Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter.
    Neyfakh AA; Borsch CM; Kaatz GW
    Antimicrob Agents Chemother; 1993 Jan; 37(1):128-9. PubMed ID: 8431010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multidrug efflux transporter of Bacillus subtilis is a structural and functional homolog of the Staphylococcus NorA protein.
    Neyfakh AA
    Antimicrob Agents Chemother; 1992 Feb; 36(2):484-5. PubMed ID: 1605617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus.
    Markham PN; Westhaus E; Klyachko K; Johnson ME; Neyfakh AA
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2404-8. PubMed ID: 10508015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus.
    Kaatz GW; Seo SM; Ruble CA
    Antimicrob Agents Chemother; 1993 May; 37(5):1086-94. PubMed ID: 8517696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the existence of a multidrug efflux transporter distinct from NorA in Staphylococcus aureus.
    Kaatz GW; Seo SM; O'Brien L; Wahiduzzaman M; Foster TJ
    Antimicrob Agents Chemother; 2000 May; 44(5):1404-6. PubMed ID: 10770791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome.
    Ng EY; Trucksis M; Hooper DC
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1345-55. PubMed ID: 8092836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible NorA-mediated multidrug resistance in Staphylococcus aureus.
    Kaatz GW; Seo SM
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2650-5. PubMed ID: 8592996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of NorA inhibition on the activities of levofloxacin, ciprofloxacin and norfloxacin against two genetically related strains of Staphylococcus aureus in an in-vitro infection model.
    Aeschlimann JR; Kaatz GW; Rybak MJ
    J Antimicrob Chemother; 1999 Sep; 44(3):343-9. PubMed ID: 10511401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus.
    Aeschlimann JR; Dresser LD; Kaatz GW; Rybak MJ
    Antimicrob Agents Chemother; 1999 Feb; 43(2):335-40. PubMed ID: 9925528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efflux pump-mediated quinolone resistance in Staphylococcus aureus strains wild type for gyrA, gyrB, grlA, and norA.
    Muñoz-Bellido JL; Alonzo Manzanares M; Martínez Andrés JA; Guttiérrez Zufiaurre MN; Ortiz G; Segovia Hernández M; García-Rodríguez JA
    Antimicrob Agents Chemother; 1999 Feb; 43(2):354-6. PubMed ID: 9925531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus.
    Schmitz FJ; Fluit AC; Lückefahr M; Engler B; Hofmann B; Verhoef J; Heinz HP; Hadding U; Jones ME
    J Antimicrob Chemother; 1998 Dec; 42(6):807-10. PubMed ID: 10052906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NorA functions as a multidrug efflux protein in both cytoplasmic membrane vesicles and reconstituted proteoliposomes.
    Yu JL; Grinius L; Hooper DC
    J Bacteriol; 2002 Mar; 184(5):1370-7. PubMed ID: 11844766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized efflux assay for the NorA multidrug efflux pump in Staphylococcus aureus.
    Zimmermann S; Tuchscherr L; Rödel J; Löffler B; Bohnert JA
    J Microbiol Methods; 2017 Nov; 142():39-40. PubMed ID: 28887002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The multidrug efflux pump NorA is not required for salicylate-induced reduction in drug accumulation by Staphylococcus aureus.
    Price CT; Kaatz GW; Gustafson JE
    Int J Antimicrob Agents; 2002 Sep; 20(3):206-13. PubMed ID: 12385700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the multidrug transporter NorA prevents emergence of norfloxacin resistance in Staphylococcus aureus.
    Markham PN; Neyfakh AA
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2673-4. PubMed ID: 8913490
    [No Abstract]   [Full Text] [Related]  

  • 16. NorA plasmid resistance to fluoroquinolones: role of copy number and norA frameshift mutations.
    Sun L; Sreedharan S; Plummer K; Fisher LM
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1665-9. PubMed ID: 8807059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of a novel efflux-related multidrug resistance phenotype in Staphylococcus aureus.
    Kaatz GW; Moudgal VV; Seo SM
    J Antimicrob Chemother; 2002 Dec; 50(6):833-8. PubMed ID: 12461001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity and inhibition of the NorA efflux pump of Staphylococcus aureus by extract and isolated compounds from Arrabidaea brachypoda.
    de Sousa Andrade LM; de Oliveira ABM; Leal ALAB; de Alcântara Oliveira FA; Portela AL; de Sousa Lima Neto J; de Siqueira-Júnior JP; Kaatz GW; da Rocha CQ; Barreto HM
    Microb Pathog; 2020 Mar; 140():103935. PubMed ID: 31857236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of a norA promoter region mutation into the chromosome of a fluoroquinolone-susceptible strain of Staphylococcus aureus using plasmid integration.
    Kaatz GW; Seo SM; Foster TJ
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2222-4. PubMed ID: 10471568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump.
    Sabatini S; Kaatz GW; Rossolini GM; Brandini D; Fravolini A
    J Med Chem; 2008 Jul; 51(14):4321-30. PubMed ID: 18578473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.